Systemic biomarkers currently implicated in the formation of abdominal wall hernia: A systematic review of the literature

Am J Surg. 2021 Jul;222(1):56-66. doi: 10.1016/j.amjsurg.2020.10.039. Epub 2020 Nov 6.

Abstract

Background: Surgery to the abdominal wall is ubiquitous worldwide and hernia treatment is challenging and expensive, posing a critical need to tailor treatment to individual patient risk-factors. In this systematic review, we consider specific systemic factors with potential as biomarkers of hernia formation.

Methods: A healthcare database-assisted search, following PRISMA guidelines, identified journal articles for inclusion and analysis.

Results: 14 biomarker studies were selected, comparing hernia patients and hernia-free controls, focusing on markers of extracellular matrix (ECM) remodelling and collagen turnover. Matrix metalloproteinase-2 was increased in patients with inguinal hernia. Markers of type IV collagen synthesis were increased in patients with abdominal wall hernia; while markers of fibrillar collagen synthesis were reduced. Additional other ECM signalling proteins differ significantly within published studies.

Conclusion: We identify a lack of high-quality evidence of systemic biomarkers in tailoring treatment strategies relative to patient-specific risks, but recognise the potential held within biomarker-based diagnostic studies to improve management of hernia pathogeneses.

Keywords: Biomarkers; Collagen turnover; Extracellular matrix (ECM) remodelling; Hernia; Incisional hernia; Inguinal hernia.

Publication types

  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Abdominal Wall / pathology*
  • Biomarkers / blood
  • Biomarkers / metabolism
  • Collagen Type IV / biosynthesis*
  • Extracellular Matrix / pathology*
  • Hernia, Abdominal / blood
  • Hernia, Abdominal / diagnosis*
  • Hernia, Abdominal / etiology
  • Hernia, Abdominal / pathology
  • Humans
  • Matrix Metalloproteinase 2 / blood*
  • Matrix Metalloproteinase 2 / metabolism
  • Prognosis
  • Risk Assessment / methods

Substances

  • Biomarkers
  • Collagen Type IV
  • MMP2 protein, human
  • Matrix Metalloproteinase 2